Richalet J P, Robach P, Jarrot S, Schneider J C, Mason N P, Cauchy E, Herry J P, Bienvenu A, Gardette B, Gortan C
Association pour la Recherche en Physiologie de l'Environnement, Laboratoire Réponses cellulaires et fonctionnelles à l'hypoxie (EA 2363), U.F.R. Médecine, Université Paris Nord, Bobigny, France.
Adv Exp Med Biol. 1999;474:297-317.
Exposure to high altitude induces physiological or pathological modifications that are not always clearly attributable to a specific environmental factor: hypoxia, cold, stress, inadequate food. The principal goal of hypobaric chamber studies is to determine the specific effect of hypoxia. Eight male volunteers ("altinauts"), aged 23 to 37 were selected. They were first preacclimatized in the Observatoire Vallot (4,350 m) before entering the chamber. The chamber was progressively decompressed down to 253 mmHg barometric pressure, with a recovery period of 3 days at 5,000 m in the middle of the decompression period. They spent a total of 31 days in the chamber. Eighteen protocols were organized by 14 European teams, exploring the limiting factors of physical and psychological performance, and the pathophysiology of acute mountain sickness (AMS). All subjects reached 8,000 m and 7 of them reached the simulated altitude of 8,848 m. Three altinauts complained of transient neurological symptoms which resolved rapidly with reoxygenation. Body weight decreased by 5.4 kg through a negative caloric balance. Only four days after the return to sea-level, subjects had recovered 3.4 kg, i.e. 63% of the total loss. At 8,848 m (n = 5), PaO2 was 30.6 +/- 1.4 mmHg, PCO2 11.9 +/- 1.4 mmHg, pH 7.58 +/- 0.02 (arterialized capillary blood). Hemoglobin concentration increased from 14.8 +/- 1.4 to 18.4 +/- 1.5 g/dl at 8,000 m and recovered within 4 days at sea-level. AMS score increased rapidly at 6,000 m and was maximal at 7,000 m, especially for sleep. AMS was related to alteration in color vision and elevation of body temperature. VO2MAX decreased by 59% at 7,000 m. The purpose of this paper is to give a general description of the study and the time course of the main clinical and physiological parameters. The altinauts reached the "summit" (for some of them three consecutive times) in better physiological conditions than it would have been possible in the mountains, probably because acclimatization and other environmental factors such as cold and nutrition were controlled.
暴露于高海拔会引发生理或病理改变,这些改变并不总是能明确归因于某个特定的环境因素:缺氧、寒冷、压力、食物不足。低压舱研究的主要目的是确定缺氧的具体影响。挑选了8名年龄在23至37岁之间的男性志愿者(“高空宇航员”)。他们在进入舱室之前,先在瓦洛天文台(海拔4350米)进行预适应。舱室逐渐减压至气压253毫米汞柱,在减压过程中间有3天在5000米高度的恢复期。他们在舱室内共度过31天。14个欧洲团队组织了18个实验方案,探究身体和心理表现的限制因素以及急性高山病(AMS)的病理生理学。所有受试者都达到了8000米高度,其中7人达到了模拟的8848米高度。3名高空宇航员抱怨出现短暂的神经症状,吸氧后迅速缓解。由于热量摄入负平衡,体重下降了5.4千克。回到海平面仅4天后,受试者就恢复了3.4千克,即总损失的63%。在8848米高度(n = 5)时,动脉化毛细血管血的动脉血氧分压(PaO2)为30.6±1.4毫米汞柱,二氧化碳分压(PCO2)为11.9±1.4毫米汞柱,pH值为7.58±0.02。血红蛋白浓度在8000米时从14.8±1.4克/分升增加到18.4±1.5克/分升,并在回到海平面4天内恢复。AMS评分在6000米时迅速上升,在7000米时达到最高,尤其是在睡眠方面。AMS与色觉改变和体温升高有关。在7000米时,最大摄氧量(VO2MAX)下降了59%。本文旨在对该研究以及主要临床和生理参数的时间进程进行总体描述。高空宇航员达到“顶峰”(其中一些人连续三次)时的生理状况比在山区可能达到的状况更好,这可能是因为适应过程以及寒冷和营养等其他环境因素得到了控制。